Home » Topics » Regulatory » Patents

Patents
RSS

Redx Pharma discovers new compounds promoting interferon alpha production

Jan. 19, 2017

Academia Sinica discloses new glucagon-like peptide 1 modulators

Jan. 19, 2017

SignalChem Lifesciences describes novel carbonic anhydrase 9, 12 inhibtors

Jan. 19, 2017

Exelixis discovers new S1P1 and S1P5 receptor agonists

Jan. 19, 2017

Orion presents novel bromodomain-containing protein 4 inhibitors

Jan. 18, 2017

GlaxoSmithKline describes new indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 18, 2017

Wockhardt presents novel bicyclic antibacterial activity enhancers

Jan. 18, 2017

Nimbus Therapeutics patents IRAK-4 inhibitors

Jan. 18, 2017

Merck & Co. discloses novel PI3Kdelta inhibtors

Jan. 18, 2017

Pierre Fabre reports Plk-1 inhibitors

Jan. 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...